![James Bucher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Bucher
Generell Rådgivare på
HARPOON THERAPEUTICS, INC.
Förmögenhet: - $ per 2026-06-30
Profil
James B. Bucher currently works at Harpoon Therapeutics, Inc., as Chief Legal Officer from 2023 and Zentalis Pharmaceuticals, Inc., as Secretary & Chief Legal Officer from 2025.
Mr. Bucher also formerly worked at Exelixis, Inc., as Secretary & Vice President-Corporate Legal Affairs from 2013 to 2014, Shearman & Sterling LLP, as Partner from 2001 to 2007, Lundbeck Seattle BioPharmaceuticals, Inc., as Executive Vice President & General Counsel, and Climb Bio, Inc., as Executive Vice President & General Counsel.
Mr. Bucher received his undergraduate degree from Colgate University and graduate degree from Emory University School of Law.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-20 | 0 ( -.--% ) | - $ | 2026-06-30 |
Aktiva positioner av James Bucher
| Företag | Position | Start |
|---|---|---|
| HARPOON THERAPEUTICS, INC. | Generell Rådgivare | 2023-12-26 |
| ZENTALIS PHARMACEUTICALS, INC. | Generell Rådgivare | 2025-09-18 |
Tidigare kända positioner av James Bucher
| Företag | Position | Slut |
|---|---|---|
| EXELIXIS, INC. | Generell Rådgivare | 2014-01-01 |
Shearman & Sterling LLP
 Shearman & Sterling LLP Miscellaneous Commercial ServicesCommercial Services Operates as a law firm | Företagsledare/Principal | 2007-01-01 |
| CLIMB BIO, INC. | Generell Rådgivare | - |
| ALDER BIOPHARMACEUTICALS, INC. | Generell Rådgivare | - |
James Buchers utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
81
Första gradens relationer
8
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 8 |
|---|---|
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Shearman & Sterling LLP
Shearman & Sterling LLP Miscellaneous Commercial ServicesCommercial Services Operates as a law firm | Commercial Services |
Colgate University
 Colgate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
Emory University School of Law
 Emory University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immunotherapy company that develops T-cell engagers to treat cancer and other diseases | Health Technology |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Zentalis Pharmaceuticals, Inc.
 Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
